Get informed when a big investor buys or sells
+ FollowOvervalued by 80.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $17.38 Million |
|---|---|
| Enterprise Value | $17.37 Million |
| Earnings per Share | $0 |
| Beta | -1.46 |
| Outstanding Shares | 206,904,585 |
| P/E Ratio | -70 |
|---|---|
| PEG | 64.94 |
| Price to Sales | - |
| Price to Book Ratio | -0.08 |
| Enterprise Value to Revenue | 9.2 |
| Enterprise Value to EBIT | -78.22 |
| Enterprise Value to Net Income | -71 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -32.1 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
DSwiss, Inc. is a biotech-nutraceutical company that supplies a comprehensive range of health and beauty products. Its market reach extends across Malaysia, Singapore, Indonesia, Taiwan, Macau, Hong Kong, and China. The company's product...